Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Investors use market indices for benchmarking, asset allocation, and risk management, enabling efficient, cost-effective exposure to markets.
27,738 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Target’s stock has surged 33% from October lows, prompting renewed questions about a possible buyout. This report ana...
Uber is acquiring SpotHero to add parking reservations inside the Uber app, a move that signals a broader push to tur...
Retirees eye InfraCap MLP ETF AMZA for a high yield amid volatile markets. This report highlights critical factors re...
As markets swing in early 2026, three actively-managed ETFs are drawing inflows for steady income and downside protec...
Hidden Road's NSCC integration marks a milestone for Ripple's XRP ecosystem as RLUSD grows, boosting liquidity and in...
Carl Icahn steps back from the activist spotlight as Michael Dell solidifies a long-term playbook for Dell Technologi...
When a top executive sells a large block of shares, investors want clarity. This guide breaks down what RingCentral's...
A quartet of high-yield ETFs are now producing double-digit income in 2026, each using a different approach. Here's a...
As AI hype accelerates, Clarivate (CLVT) quietly leans on its defensible data assets to reduce debt and position for ...
Credo Technology delivers a blockbuster Q3, yet Marvell’s AI data-center push steals the spotlight. Investors are ret...
A look at five 2016 IPOs shows how a $1,000 investment in each would have fared through 2026, highlighting divergent ...